STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has announced its participation in two upcoming healthcare conferences in September 2024. The company will be present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 at 9:15 a.m. ET in New York City, and the Wells Fargo 2024 Healthcare Conference on September 5 at 3:45 p.m. ET in Boston.

RxSight specializes in providing high-quality customized vision to patients following cataract surgery. Both conference appearances will feature fireside chats with company representatives. Interested parties can access live and archived webcasts of these events through the company's investor relations website at https://investors.rxsight.com/.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+3.90% News Effect

On the day this news was published, RXST gained 3.90%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST– RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September.

  • Morgan Stanley 22nd Annual Global Healthcare Conference
    - Fireside Chat: Wednesday, September 4, 2024, at 9:15 a.m. ET in New York City, NY
  • Wells Fargo 2024 Healthcare Conference
    - Fireside Chat: Thursday, September 5, 2024, at 3:45 p.m. ET in Boston, MA

Interested parties may access live and archived webcasts of these events at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+™, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com


FAQ

When and where will RxSight (RXST) participate in the Morgan Stanley healthcare conference?

RxSight (RXST) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 9:15 a.m. ET in New York City, NY.

What is the date and time for RxSight's (RXST) fireside chat at the Wells Fargo healthcare conference?

RxSight's (RXST) fireside chat at the Wells Fargo 2024 Healthcare Conference is scheduled for Thursday, September 5, 2024, at 3:45 p.m. ET in Boston, MA.

How can investors access the webcasts of RxSight's (RXST) conference appearances?

Investors can access live and archived webcasts of RxSight's (RXST) conference appearances at https://investors.rxsight.com/.

What type of medical devices does RxSight (RXST) specialize in?

RxSight (RXST) specializes in ophthalmic medical devices that provide high-quality customized vision to patients following cataract surgery.
Rxsight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Latest SEC Filings

RXST Stock Data

516.42M
38.59M
5.56%
96.93%
13.31%
Medical Devices
Ophthalmic Goods
Link
United States
ALISO VIEJO